Domain IV of elongation factor G from Thermus thermophilus is strictly required for translocation  by Martemyanov, Kirill A & Gudkov, Anatoly T
Domain IV of elongation factor G from Thermus thermophilus is strictly
required for translocation
Kirill A. Martemyanov, Anatoly T. Gudkov*
Institute of Protein Research, Russian Academy of Sciences, 142292 Pushchino, Russia
Received 9 April 1999; received in revised form 20 April 1999
Abstract Two truncated variants of elongation factor G from
Thermus thermophilus with deletion of its domain IV have been
constructed and the mutated genes were expressed in Escherichia
coli. The truncated factors were produced in a soluble form and
retained a high thermostability. It was demonstrated that
mutated factors possessed (1) a reduced affinity to the ribosomes
with an uncleavable GTP analog and (2) a specific ribosome-
dependent GTPase activity. At the same time, in contrast to the
wild-type elongation factor G, they were incapable to promote
translocation. The conclusions are drawn that (1) domain IV is
not involved in the GTPase activity of elongation factor G, (2) it
contributes to the binding of elongation factor G with the
ribosome and (3) is strictly required for translocation. These
results suggest that domain IV might be directly involved in
translocation and GTPase activity of the factor is not directly
coupled with translocation.
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1. Introduction
Elongation factors (EF) Tu and G play a crucial role in the
ribosomal elongation cycle. EF-Tu delivers cognate aminoac-
yl-tRNA into the ribosome and EF-G stimulates peptidyl-
tRNA transfer from the A to P ribosomal sites and mRNA
movement, i.e. translocation [1]. Recent studies of EFs re-
sulted in a tertiary structure determination of EF-G from
Termus thermophilus in the complex with GDP and its empty
form [2,3], EF-Tu from T. thermophilus in GTP forms [4] and
the ternary complex of EF-Tu with the uncleavable GTP ana-
log and aminoacylated tRNA [5]. It is interesting that the
overall shape of EF-G has been found very similar to that
of the EF-Tu complex with the aminoacyl-tRNA and uncleav-
able GTP analog [6,7]. The most remarkable is that domains
III, IV and V of EF-G mimic the tRNA structure in the EF-
Tu ternary complex and, in this case, domain IV can be re-
lated to the anticodon arm of tRNA. This ‘molecular mimi-
cry’ is thought to be functionally important [7^10].
To study the functional role of domain IV, we prepared two
truncated variants of EF-G from T. thermophilus without do-
main IV. All principal activities of EF-G were investigated
and it was demonstrated that the mutated factors possessed a
speci¢c ribosome-dependent GTPase activity, whilst their
translocation ability was abolished.
2. Materials and methods
2.1. Materials
Restriction endonucleases and T4 DNA ligase were from Promega.
DNA polymerase was purchased from New England Biolabs and used
according to the manufacturer’s directions. Resins for protein isola-
tion, Q-Sepharose FF, Ultrogel Ac34 and HA-Ultrogel were from
Pharmacia. Plasmids were maintained in Escherichia coli strain XL1
(Promega). For gene expression, plasmid pET 11c and strains
BL21(DE3) or B834(DE3) (Novagen) were used [11].
2.2. Oligonucleotides
The following oligonucleotides for mutagenesis were synthesized by
Gene Assembler Plus (Pharmacia) according to the manufacturer’s
manual: Pr1, 5P-CGGTGGTGCATATGGCGGTCAAGGTAG-3P,
contains restriction site NdeI; Pr2, 5P- ATCTCCGTCCTGATCAC-
AAGGAAGGG-3P, (site BclI); Pr3, 5P-CCGGTAGTCGACCTG-
GGGCTTGC-3P, (site SalI); Pr4, 5P-GTGATCGTCGACCCCAT-
CATGC-3P, (site SalI); Pr5, 5P-GGGAATTCTTAGTGGTCAAA-
GAACA-3P with a stop codon and EcoRI site; Pr6, 5P-CTC-
CACGTCGACCGGCTT-3P, (site SalI); Pr7, 5P-CAGAAGGTCGA-
CCCGGTGA-3P, (site SalI). The restriction sites are given in italic,
non-complementary nucleotides are given in bold letters.
2.3. Mutagenesis, gene expression and protein puri¢cation
Mutagenesis was carried out by polymerase chain reaction (PCR).
All other recombinant DNA procedures were according to the pub-
lished manual [12]. Two independent PCR reactions were carried with
primers (either Pr1 and Pr3 or P4 and pr5) as in reference [13]. The
two PCR products were puri¢ed with a ‘Wizard PCR preps kit’
(Promega) and digested either with NdeI and SalI or with SalI and
EcoRI. The obtained fragments were simultaneously ligated into the
pET11c plasmid treated with NdeI and EcoRI. In this way, the ex-
pression plasmid pETvIVC was obtained with the DNA fragment
encoding the EF-GvIVC protein. The second plasmid, pETGvIV,
was constructed in a similar way using primers Pr1, Pr6 and primers
Pr2, Pr7. This plasmid carries the gene for the EF-GvIV protein (see
Section 3).
Cloned genes were expressed according to the published procedure
[11]. A heat denaturation approach was used due to the high thermo-
stability of the produced proteins [13]. The purity of the isolated
proteins was checked by SDS electrophoresis [14].
2.4. Nucleotide binding and GTP hydrolysis
Complex formation of EF with the ribosomes and uncleavable GTP
analog was tested by the ¢lter binding technique [15]. To test weak
interactions of the truncated factors with ribosomes and GMPPNP,
the sedimentation technique was used [16]. After centrifugation, ali-
quots of 50 Wl were carefully withdrawn, mixed with 20 Wl of the
sample electrophoresis bu¡er and loaded on the gel for SDS electro-
phoresis. The distribution of EF-G in the fractions was registered by a
HP Jet Scanner after gel staining by Coomassie G-250. Band inten-
sities were quanti¢ed with the help of the Kodak 1D program.
Uncoupled GTPase activity of EF-G with the ribosomes was fol-
lowed spectrophotometrically by measuring released inorganic phos-
phate as described in [17].
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2.5. Translation in vitro
Poly(U)-directed polyphenylalanine synthesis was carried out in a
cell-free translation system with puri¢ed EF-Tu and EF-G according
to the published procedure [18]. The stimulation of non-enzymatic
translation by EF-G and deletion mutants was tested as described
[19]. Translocation activities of the factors were also checked by com-
petence of the ribosomal complex to puromycin. In this case, the pre-
translocation complex was prepared as described in [20]. The puro-
mycin reaction was carried out with 40 pmol of the factors, 45 pmol
of the ribosomes and 1 mM (¢nal concentration) of puromycin as in
[21].
3. Results
3.1. Structural characteristics of the truncated EF-G
The EF-G tertiary structure [2,3] was considered in muta-
genesis planning. It was noticed that Val-481 and Pro-604, as
well as Asp-492 and Pro-599, are spatially close in the EF-G
tertiary structure. It was di⁄cult to predict the stability of the
truncated factors. For this reason, the residues between these
neighboring amino acids were deleted and two truncated var-
iants of EF-G were independently obtained.
The ¢rst mutated EF-G with deleted residues 493^598 is
designated as EF-GvIV. This protein contains an intact C-
terminal helical fragment, two short L-strands of the domain
IV and its residues Asp-492 and Pro-599 are directly con-
nected. In the second construct, a new stop codon was in-
serted instead of Tyr-676. As a result, the EF-GvIVC protein
was obtained with deleted residues 482^603 and one foreign
amino acid (Asp) inserted after Val-481. The C-terminal res-
idues 676^691 constituted the C-terminal helix were also ex-
cised (Fig. 1).
The EF-GvIVC and EF-GvIV proteins contain 554 and
585 amino acids (including N-terminal Met) with molecular
weights of 61 900 and 65 509, respectively.
Both truncated factors produced in the cells were stable up
to 70‡C. At this temperature, the EF-G from E. coli is com-
pletely inactivated and precipitated [22]. For this reason, a
heat denaturation step was used for protein puri¢cation.
3.2. Binding to the ribosomes and GTPase activity
The mutated factors under study displayed very similar
functional activities and all given data below are related to
the both of them.
Fig. 1. Ribbon models of the tertiary structures of intact T. thermophilus EF-G and its truncated variants. Arrows indicate new connections
after domain IV excision (see text). The helix between domains IV and V is a C-terminal helix. The models were drawn with the help of RAS-
MOL program using PDB coordinates (PDB ID. 1DAR).
Table 1
Ribosomal complex formation with EF-G and uncleavable GTP analog
Mixture compositiona EF-Gb ratio in fractions Complex formationc (%)
EF-G, GMPPNP, 70S Rs 31.2 100
EF-G, GMPPNP, 70S Rs, 75 WM thiostrepton 1.2 0.2
EF-G, GMPPNP 1.2 ^
EF-GvIV, GMPPNP, 70S, RS 5.6 14.5
EF-GvIV, GMPPNP, 70S Rs, 75WM thiostrepton 3.4 7.5
EF-GvIV, GMPPNP 1.1 ^
aT. thermophilus EF-G and E. coli 70S ribosomes were used.
bThe ratios of the EF-G amount in the bottom/supernatant fractions are given in arbitrary units. The S.D.s are þ 0.1.
cThe amount of wild-type EF-G bound to the ribosomes was taken as 100%.
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The binding studies of the truncated factors have shown
their decreased a⁄nity to the 70S ribosomes. In contrast to
the wild-type EF-G, the ribosomal complexes with the mutant
proteins and uncleavable GTP analog (GMPPNP) could not
be detected by the ¢lter binding technique. The existence of
the complexes was demonstrated by centrifugation and elec-
trophoresis analysis. The complex formation was inhibited by
thiostrepton. In case of EF-GvIV, the inhibition e¡ect was
less pronounced than for intact EF-G (Table 1). The binding
of the truncated factors to isolated 50S subunits was even
weaker (not shown).
The GTPase activity of the truncated factors speci¢cally
depended on the 70S ribosomes or the 50S subunits but did
not depend on the 30S subunits. The EF-GvIV and EF-G
from E. coli displayed similar rates of uncoupled GTP hydrol-
ysis and these rates were a little higher than in the case of
intact T. thermophilus EF-G (Fig. 2A). The rate of GTP hy-
drolysis with truncated factors and the 50S subunit was slower
than with a 70S ribosome (Fig. 2B).
The fusidic acid (FA) inhibited the ribosome-dependent
GTP hydrolysis promoted by wild-type EF-G and EF-
GvIV. A half-inhibition e¡ect is less than 50 WM FA (titration
curve not shown).
3.3. Translation activity
The EF-G from T. thermophilus was capable to substitute
the EF-G from E. coli in the poly(U)-directed translation
system with E. coli ribosomes [13]. The translation activity
of T. thermophilus EF-G was similar to that of E. coli EF-
G, but the truncated proteins were not active in the poly(U)-
directed translation system (Fig. 3).
The translocation ability of the mutant proteins was also
tested in the non-enzymatic translation system [19]. The trun-
cated factors virtually had no stimulation e¡ect in this system.
During 5 h of incubation, 18 pmol of poly-Phe was synthe-
sized in the system supplemented with wild-type EF-G and
only about 3 pmol (a comparable value for ‘factor-free’ sys-
tem) in the presence of EF-GvIV. EF-GvIV was also not
active in a puromycin reaction with pre-translocation ribo-
somes. The yield of Phe-puromycin was comparable with its
formation in the experiment without the EF-G (Fig. 4), even
at a 5-fold excess of the EF-GvIV over ribosomes.
4. Discussion
The progress in the structural studies of EF-Tu and -G have
led to the observation of the molecular mimicry between EF-
G and the ternary complex of the EF-Tu with tRNA. In this
case, EF-G domain IV is a particularly interesting part of the
factor. Its relationships to the anticodon arm of the tRNA in
the ternary complex raises the question whether this is an
important EF-G part for translocation.
Years ago, it was shown [15] that EF-Tu and -G from T.
thermophilus can substitute their counterparts from E. coli in
reactions with E. coli ribosomes. This was con¢rmed by the
EF-G produced in E. coli from the cloned fus gene of T.
thermophilus [13].
Both wild-type EF-G and EF-GvIV promoted GTP hydrol-
ysis with the 70S and 50S particles. Isolated 30S subunits do
not stimulate GTPase activity, but they do so in the 70S
ribosome by improving the interaction of the factors with
Fig. 2. Kinetics of GTP hydrolysis by EF-G and EF-GvIV on the
70S ribosomes and ribosomal subunits. (A) The 70S ribosomes pre-
sented in all cases, (Y) EF-GvIV, (S) E. coli EF-G, (b) T. Thermo-
philus EF-G, (+) no EF-G; (B) (Y) EF-GvIV with the 70S ribo-
somes, (P) EF-GvIV with 50S subunits, (R) 50S with no EF-G
and (+) EF-GvIV with 30S subunits. Values for the phosphate re-
leased are given for 20 Wl aliquots.
Fig. 3. Poly(U)-directed cell-free translation. (b) With wild-type T.
thermophilus and (S) E. coli EF-G, (Y) with the truncated factor
and (+) 30S without EF-G. Values are given for 10 Wl aliquots.
Fig. 4. The yield of Phe-puromycin in reaction with pre-transloca-
tion ribosomes promoted by: (b) wild-type EF-G, (Y) by EF-GvIV,
(+) no EF-G added. The yield was calculated for the total reaction
mixture.
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50S subunits [23,24]. The EF-G interacts with both subunits
of the ribosome and domain IV has contacts with the 30S
subunit [25]. Hence, the decreased a⁄nity of EF-GvIV to
the ribosome (Table 1) can be explained by the absence of
domain IV. This may also explain the increased GTPase ac-
tivity of the EF-GvIV (Fig. 2A). In such an event, incomplete
contacts of the truncated factor with the ribosome may pre-
vent some conformational adjustments (both in the ribosome
and in EF-G) which occur in the case of intact EF-G. Con-
sequently, it may facilitate dissociation of EF-GvIV after
GTP hydrolysis and the hydrolysis turnover will be increased.
These results also suggest that (1) either the 50S subunit has
a somewhat di¡erent conformation in the 70S ribosome or (2)
some conformational changes could occur in the 70S ribo-
some and/or in the intact EF-G upon its binding to the ribo-
some, but in the case of EF-GvIV, this does not happen.
These suggestions are in agreement with the data and discus-
sions available in the literature on conformational changes in
the ribosomes and EFs upon their interaction [4,23,25^29].
Analysis of FA resistant mutations in EF-G placed them in
the G domain and at the interface between domains G, II, III
and V [9]. Since FA inhibits GTP hydrolysis catalyzed by a
truncated factor, we conclude that these domains are intact in
EF-GvIV and domain IV deletion does not in£uence the FA
mode of action markedly.
The truncated factor was not active in poly(U)-directed
translation (Fig. 3). EF-GvIV also had no stimulatory e¡ect
on the non-enzymatic translation (see the Section 3), though
this system is known as a sensitive test for the translocation
ability of EF-G [19]. In contrast to the wild-type EF-G, no
activity was found in the EF-GvIV-dependent puromycin re-
action with isolated pre-translocation ribosomes (Fig. 4).
These data indicate convincingly that factors lacking domain
IV do not promote translocation in all tested translation sys-
tems. The essential role of domain IV for translocation was
demonstrated also by mutation of a loop at the distal end of
this domain in the T. thermophilus EF-G. The insertion of six
amino acids into the loop greatly decreased the translocation
ability of the EF-G, while its GTPase activity was not a¡ected
[30].
Hence, from the data obtained, it can be concluded that (1)
domain IV contributes to the EF-G binding to the ribosomes,
(2) EF-GvIV possesses a speci¢c ribosome-dependent GTPase
activity (multiple turnover) and (3) EF-G lacking domain IV
is not active in translocation, so that the GTP hydrolysis
catalyzed by the EF-GvIV is uncoupled with translocation.
Recent studies of E. coli EF-G with a deleted domain IV
have shown that domain IV was not strictly required for
translocation. This mutant factor was found irreversibly
bound to the ribosome and for this reason, its activities
were restricted to a single round of GTP hydrolysis as well
as to a single translocation [31]. Its irreversible binding to the
ribosome after GTP hydrolysis seems very unusual. If we
assume that an E. coli truncated factor will dissociate nor-
mally, then, its function would be virtually the same as of
wild-type E. coli EF-G. The truncated E. coli factor produced
in E. coli cells was insoluble and had to be renatured from
urea before usage. This di¡erence may relate to the functional
features observed for truncated factors from E. coli and T.
thermophilus.
Several models of the EF-G function were proposed in
recent publications [10,32,33]. Since the ribosome is capable
of spontaneous translocation [34,35] and EF-G promotes
translocation with an uncleavable GTP analog, the above re-
sults support the view that EF-G catalyzes translocation by
promoting some re-arrangement in the ribosomes (not exactly
known yet). In this case, domain IV of the EF-G mimicking
the anticodon arm of tRNA may interact with the tRNA and
30S subunit [36] and, by its movement into the acceptor site,
could stimulate tRNA displacement together with mRNA, i.e.
translocation. At the same time, the GTP binding domain
interacts with the 50S subunit, GTP is hydrolyzed and the
EF-G dissociates from the ribosome. Therefore, we accept
that the GTP binding and its hydrolysis modulate the EF-G
actions basically in the same way as they do in the case of all
members of GTP binding proteins [37].
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